Abstract:Breast cancer remains the most commonly diagnosed cancer in female worldwide, marked by its molecular diversity and complex subtypes. Despite progress in targeted therapies, tumor heterogeneity and treatment resistance continue to present major challenges. Recent studies emphasize the crucial role of RNA modifications in cancer biology, with nearly 200 distinct modifications identified. Among these, methylation is particularly significant, with methylation-related factors emerging as key regulators of RNA metabolism, influencing cancer progression, metastasis, and treatment resistance. This review focuses on the roles of key RNA methylation in breast cancer, particularly N6-methyladenosine (m6A), N7-methylguanosine (m7G), 5-methylcytosine (m5C), N1-methyladenosine (m1A), and N3-methylcytidine (m3C). We examine the functions of m6A "writers" like METTL3 and METTL14, and "readers" such as the YTH domain family in modulating tumor behavior. Dysregulation of m6A "erasers" like FTO and ALKBH5 are noticed too, highlighting their impact on cancer stem cell phenotypes, chemoresistance, and immune evasion. Additionally, the role of m7G modifications in mRNA stability and translation, facilitated by METTL1/WDR4 and RNMT, is discussed as a potential therapeutic target. The involvement of m5C, m1A, and m3C modifications, particularly those mediated by NSUN2 and NSUN6, in breast cancer tumorigenesis and prognosis is also reviewed. Despite coding RNAs, the interplay between these RNA methylations and non-coding RNAs, such as lncRNAs and miRNAs, is explored, shedding light on their roles in cancer cell proliferation, invasion, and immune response modulation. This review highlights the potential of RNA methylations as novel therapeutic targets in breast cancer, offering insights for precision medicine and improved patient outcomes.

Advances in RNA Cytosine-5 Methylation: Detection, Regulatory Mechanisms, Biological Functions and Links to Cancer

The emerging significance of RNA 5-methylcytosine modification in human cancers

Biological roles of RNA m5C modification and its implications in Cancer immunotherapy

RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Deciphering the vital roles and mechanism of m5C modification on RNA in cancers

Role of Main RNA Modifications in Cancer: N6-methyladenosine, 5-Methylcytosine, and Pseudouridine

The Role of RNA M5c Modification in Cancer Metastasis.

RNA 5-Methylcytosine Modification and Its Emerging Role As an Epitranscriptomic Mark.

The Roles of M6a RNA Modifiers in Human Cancer

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Emerging Roles of RNA Methylation in Gastrointestinal Cancers

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

RNA methylations in human cancers

RNA modifications in cancer

RNA methylation and breast cancer: insights into m6A, m7G and m5C

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

Multiple functions of m6A RNA methylation in cancer

Formation and Determination of the Oxidation Products of 5-Methylcytosine in RNA

m5C RNA Methylation Primarily Affects the ErbB and PI3K–Akt Signaling Pathways in Gastrointestinal Cancer

When N7-methyladenosine modification meets cancer: Emerging frontiers and promising therapeutic opportunities